SEC Form 4 · accession 0001144204-15-030736
ANI PHARMACEUTICALS INC · ANIP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James G. Marken
Officer — Vice President, Operations
Period of report
May 13, 2015
Accepted (ET)
May 14, 2015 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001023024
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 13, 2015 | M | 7,395 | $6.36 | A | 40,463 | D | |
| Common Stock | May 13, 2015 | M | 1,625 | $33.00 | A | 42,088 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase | $6.36 | May 13, 2015 | M | 7,395 | D | Jul 12, 2014 | Jul 11, 2023 | Common Stock | 7,395 | 22,188 | D |
| Option to Purchase | $33.00 | May 13, 2015 | M | 1,625 | D | Apr 1, 2015 | Mar 31, 2024 | Common Stock | 1,625 | 4,875 | D |